Skip to main content
Journal of Assisted Reproduction and Genetics logoLink to Journal of Assisted Reproduction and Genetics
. 2002 Dec;19(12):550–554. doi: 10.1023/A:1021207014429

Human Chorionic Gonadotropin Combined with Progesterone for Luteal Support Improves Pregnancy Rate in Patients with Low Late-Midluteal Estradiol Levels in IVF Cycles

Akihisa Fujimoto 1, Yutaka Osuga 1,, Toshihiro Fujiwara 1, Tetsu Yano 1, Osamu Tsutsumi 1,2, Mikio Momoeda 1, Koji Kugu 1, Kaori Koga 1, Yutaka Morita 1, Osamu Wada 1, Yuji Taketani 1
PMCID: PMC3455835  PMID: 12503886

Abstract

Purpose: To investigate how late-midluteal estradiol levels relate to the pregnancy outcome in IVF cycles, and to assess whether human chorionic gonadotropin (hCG) for luteal support benefits the pregnancy outcome of patients with low late-midluteal estradiol levels.

Methods: The pregnancy rate of 436 women undergoing first IVF cycles with long protocol and luteal support with progesterone alone were analyzed. Unsuccessful women with low late-midluteal estradiol levels (<100 pg/mL) proceeded with the exploratory second IVF cycles where they were randomly given with either progesterone alone (P protocol) or hCG +progesterone (P+hCG protocol) for luteal support.

Results: Pregnancy rate in women with low late-midluteal estradiol levels was significantly lower compared to that with medium (100–500 pg/mL) and high (>500 pg/mL) levels (13.3, 26.8, and 36.3%, respectively). P+hCG protocol increased late-midluteal estradiol levels and produced a significantly higher pregnancy rate (31.7%) than P protocol (13.7%).

Conclusions: hCG in combination with progesterone for luteal support was suggested to benefit women undergoing IVF with low late-midluteal estradiol levels.

Keywords: Estradiol, hCG, IVF-ET, luteal support, progesterone

Full Text

The Full Text of this article is available as a PDF (55.3 KB).

REFERENCES

  • 1.Younis JS, Simon A, Laufer N. Endometrial preparation: lessons from oocyte donation. Fertil Steril. 1996;66:873–884. doi: 10.1016/s0015-0282(16)58677-4. [DOI] [PubMed] [Google Scholar]
  • 2.de Ziegler D, Bergeron C, Cornel C, Medalie DA, Massai MR, Milgrom E, Frydman R, Bouchard P. Effects of luteal estradiol on the secretory transformation of human endometrium and plasma gonadotropins. J Clin Endocrinol Metab. 1992;74:322–331. doi: 10.1210/jcem.74.2.1730810. [DOI] [PubMed] [Google Scholar]
  • 3.Younis JS, Ezra Y, Sherman Y, Simon A, Schenker JG, Laufer N. The effect of estradiol depletion during the luteal phase on endometrial development. Fertil Steril. 1994;62:103–107. doi: 10.1016/s0015-0282(16)56823-x. [DOI] [PubMed] [Google Scholar]
  • 4.Muasher S, Acosta AA, Garcia JE, Jones GS, Jones HW., Jr Luteal phase serum estradiol and progesterone in in vitro fertilization. Fertil Steril. 1984;41:838–843. doi: 10.1016/s0015-0282(16)47895-7. [DOI] [PubMed] [Google Scholar]
  • 5.Nylund L, Beskow C, Carlstrom K, Fredricsson B, Gustafson O, Lunell NO, Pousette A, Rosenborg L, Slotte H, Akerlof E. The early luteal phase in successful and unsuccessful implantation after IVF-ET. Hum Reprod. 1990;5:40–42. doi: 10.1093/oxfordjournals.humrep.a137037. [DOI] [PubMed] [Google Scholar]
  • 6.Smitz J, Bourgain C, Van Waesberghe L, Camus M, Devroey P, Van Steirteghem AC. A prospective randomized study on oestradiol valerate supplementation in addition to intravaginal micronized progesterone in buserelin and HMG induced superovulation. Hum Reprod. 1993;8:40–45. doi: 10.1093/oxfordjournals.humrep.a137871. [DOI] [PubMed] [Google Scholar]
  • 7.Hutchinson-Williams KA, Lunenfeld B, Diamond MP, Lavy G, Boyers SP, DeCherney AH. Human chorionic gonadotropin, estradiol, and progesterone profiles in conception and nonconception cycles in an in vitro fertilization program. Fertil Steril. 1989;52:441–445. doi: 10.1016/s0015-0282(16)60915-9. [DOI] [PubMed] [Google Scholar]
  • 8.Sharara FI, McClamrock HD. Ratio of oestradiol concentration on the day of human chorionic gonadotrophin administration to mid-luteal oestradiol concentration is predictive of in-vitro fertilization outcome. Hum Reprod. 1999;14:2777–2782. doi: 10.1093/humrep/14.11.2777. [DOI] [PubMed] [Google Scholar]
  • 9.Yu Ng EH, Yeung WS, Yee Lan LE, So WW, Ho PC. High serum oestradiol concentrations in fresh IVF cycles do not impair implantation and pregnancy rates in subsequent frozenthawed embryo transfer cycles. Hum Reprod. 2000;15:250–255. doi: 10.1093/humrep/15.2.250. [DOI] [PubMed] [Google Scholar]
  • 10.Buvat J, Marcolin G, Guittard C, Herbaut JC, Louvet AL, Dehaene JL. Luteal support after luteinizing hormonereleasing hormone agonist for in vitro fertilization: Superiority of human chorionic gonadotropin over oral progesterone. Fertil Steril. 1990;53:490–494. doi: 10.1016/s0015-0282(16)53346-9. [DOI] [PubMed] [Google Scholar]
  • 11.Claman P, Domingo M, Leader A. Luteal phase support in invitro fertilization using gonadotrophin releasing hormone analogue before ovarian stimulation: A prospective randomized study of human chorionic gonadotrophin versus intramuscular progesterone. Hum Reprod. 1992;7:487–489. doi: 10.1093/oxfordjournals.humrep.a137676. [DOI] [PubMed] [Google Scholar]
  • 12.Mochtar MH, Hogerzeil HV, Mol BW. Progesterone alone versus progesterone combined with HCG as luteal support in Gn-RHa/HMG induced IVF cycles: A randomized clinical trial. Hum Reprod. 1996;11:1602–1605. doi: 10.1093/oxfordjournals.humrep.a019453. [DOI] [PubMed] [Google Scholar]
  • 13.McClure N, Leya J, Radwanska E, Rawlins R, Haning RV., Jr Luteal phase support and severe ovarian hyperstimulation syndrome. Hum Reprod. 1992;7:758–764. doi: 10.1093/oxfordjournals.humrep.a137733. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Assisted Reproduction and Genetics are provided here courtesy of Springer Science+Business Media, LLC

RESOURCES